Eli Lilly expects to have data from a late-stage trial involving orforglipron by April. This weight loss pill helped patients lose nearly 15% of their weight in a phase 2 trial. Lilly has been a ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands Mounjaro and Zepbound, in India by 2025. However, regulatory approvals are ...

WhenInManila.com is a community of writers, photographers, videographers, and storytellers, who share their discoveries and stories about Manila, Philippines, and the world. We are the biggest blog ...

Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters. In a study sponsored by Lilly ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Ken Fisher's other top stock picks. Ken Fisher is the founder of Fisher Asset Management ...

FORT COLLINS — Lilly Downs rolled out of bed in her new apartment and began setting up her morning’s IV fluids, which flow from a tube in her chest into her bloodstream to keep the 20-year-old ...

EVANGELINE PARISH — A two-vehicle crash early Thursday morning on Louisiana Highway 13 near Gradney Lane claimed the life of a Ville Platte woman, according to Louisiana State Police. Kimberly ...